FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013256530> ?p ?o ?g. }

• W2013256530 endingPage "429" @default.
• W2013256530 startingPage "420" @default.
• W2013256530 abstract "Cancer pain is a serious public health issue and more effective treatments are needed. This study evaluates the analgesic activity of tetrodotoxin, a highly selective sodium channel blocker. This randomized, placebo-controlled, parallel design study of subcutaneous tetrodotoxin, in patients with moderate or severe unrelieved cancer pain persisting despite best available treatment, involved 22 centers across Canada. The design called for tetrodotoxin administered subcutaneously over Days 1-4 with a period of observation to Day 15 or longer. All patients could enroll into an open-label extension efficacy and safety trial. The primary endpoint was the proportion of analgesic responders in each treatment arm. Eighty-two patients were randomized, and results on 77 were available for analysis. There was a nonstatistically significant trend toward more responders in the active treatment arm based on the primary endpoint (pain intensity difference). However, analysis of secondary endpoints, and an exploratory post hoc analysis, suggested there may be a robust analgesic effect if a composite endpoint is used, including either fall in pain level, or fall in opioid dose, plus improvement in quality of life. Most patients described transient perioral tingling or other mild sensory phenomena within about an hour of each treatment. Nausea and other toxicities were generally mild, but one patient experienced a serious, adverse event, truncal and gait ataxia. This trial suggests tetrodotoxin may potentially relieve moderate to severe, treatment-resistant cancer pain in a large proportion of patients, and often for prolonged periods following treatment, but further study is warranted using a composite primary endpoint." @default.
• W2013256530 created "2016-06-24" @default.
• W2013256530 creator A5012586140 @default.
• W2013256530 creator A5025329915 @default.
• W2013256530 creator A5026494449 @default.
• W2013256530 creator A5037635084 @default.
• W2013256530 creator A5062909568 @default.
• W2013256530 creator A5082309855 @default.
• W2013256530 creator A5082812340 @default.
• W2013256530 creator A5083600483 @default.
• W2013256530 date "2008-04-01" @default.
• W2013256530 modified "2023-10-17" @default.
• W2013256530 title "Tetrodotoxin for Moderate to Severe Cancer Pain: A Randomized, Double Blind, Parallel Design Multicenter Study" @default.
• W2013256530 cites W1964023104 @default.
• W2013256530 cites W1966133272 @default.
• W2013256530 cites W1978129733 @default.
• W2013256530 cites W1991925106 @default.
• W2013256530 cites W1999408762 @default.
• W2013256530 cites W2001041106 @default.
• W2013256530 cites W2015624760 @default.
• W2013256530 cites W2017424116 @default.
• W2013256530 cites W2021615736 @default.
• W2013256530 cites W2023671892 @default.
• W2013256530 cites W2024177131 @default.
• W2013256530 cites W2027010723 @default.
• W2013256530 cites W2035889265 @default.
• W2013256530 cites W2039664528 @default.
• W2013256530 cites W2084518320 @default.
• W2013256530 cites W2093371287 @default.
• W2013256530 cites W2096329648 @default.
• W2013256530 cites W2113160492 @default.
• W2013256530 cites W2115111325 @default.
• W2013256530 cites W2139306343 @default.
• W2013256530 cites W2141918005 @default.
• W2013256530 cites W2145739946 @default.
• W2013256530 cites W2159865397 @default.
• W2013256530 cites W2170691735 @default.
• W2013256530 cites W3194956376 @default.
• W2013256530 cites W88022551 @default.
• W2013256530 doi "https://doi.org/10.1016/j.jpainsymman.2007.05.011" @default.
• W2013256530 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18243639" @default.
• W2013256530 hasPublicationYear "2008" @default.
• W2013256530 type Work @default.
• W2013256530 sameAs 2013256530 @default.
• W2013256530 citedByCount "81" @default.
• W2013256530 countsByYear W20132565302012 @default.
• W2013256530 countsByYear W20132565302014 @default.
• W2013256530 countsByYear W20132565302015 @default.
• W2013256530 countsByYear W20132565302016 @default.
• W2013256530 countsByYear W20132565302017 @default.
• W2013256530 countsByYear W20132565302018 @default.
• W2013256530 countsByYear W20132565302019 @default.
• W2013256530 countsByYear W20132565302020 @default.
• W2013256530 countsByYear W20132565302021 @default.
• W2013256530 countsByYear W20132565302022 @default.
• W2013256530 countsByYear W20132565302023 @default.
• W2013256530 crossrefType "journal-article" @default.
• W2013256530 hasAuthorship W2013256530A5012586140 @default.
• W2013256530 hasAuthorship W2013256530A5025329915 @default.
• W2013256530 hasAuthorship W2013256530A5026494449 @default.
• W2013256530 hasAuthorship W2013256530A5037635084 @default.
• W2013256530 hasAuthorship W2013256530A5062909568 @default.
• W2013256530 hasAuthorship W2013256530A5082309855 @default.
• W2013256530 hasAuthorship W2013256530A5082812340 @default.
• W2013256530 hasAuthorship W2013256530A5083600483 @default.
• W2013256530 hasBestOaLocation W20132565301 @default.
• W2013256530 hasConcept C121608353 @default.
• W2013256530 hasConcept C126322002 @default.
• W2013256530 hasConcept C141071460 @default.
• W2013256530 hasConcept C142724271 @default.
• W2013256530 hasConcept C168563851 @default.
• W2013256530 hasConcept C197934379 @default.
• W2013256530 hasConcept C203092338 @default.
• W2013256530 hasConcept C204787440 @default.
• W2013256530 hasConcept C27081682 @default.
• W2013256530 hasConcept C2778904085 @default.
• W2013256530 hasConcept C2780580376 @default.
• W2013256530 hasConcept C2780820201 @default.
• W2013256530 hasConcept C42219234 @default.
• W2013256530 hasConcept C71924100 @default.
• W2013256530 hasConceptScore W2013256530C121608353 @default.
• W2013256530 hasConceptScore W2013256530C126322002 @default.
• W2013256530 hasConceptScore W2013256530C141071460 @default.
• W2013256530 hasConceptScore W2013256530C142724271 @default.
• W2013256530 hasConceptScore W2013256530C168563851 @default.
• W2013256530 hasConceptScore W2013256530C197934379 @default.
• W2013256530 hasConceptScore W2013256530C203092338 @default.
• W2013256530 hasConceptScore W2013256530C204787440 @default.
• W2013256530 hasConceptScore W2013256530C27081682 @default.
• W2013256530 hasConceptScore W2013256530C2778904085 @default.
• W2013256530 hasConceptScore W2013256530C2780580376 @default.
• W2013256530 hasConceptScore W2013256530C2780820201 @default.
• W2013256530 hasConceptScore W2013256530C42219234 @default.
• W2013256530 hasConceptScore W2013256530C71924100 @default.
• W2013256530 hasIssue "4" @default.
• W2013256530 hasLocation W20132565301 @default.
• W2013256530 hasLocation W20132565302 @default.
• W2013256530 hasOpenAccess W2013256530 @default.

• next